A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT07098338 · RECRUITING

Trial details

NCT number: NCT07098338
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2025-08-07
Primary completion: 2029-04-06
Enrollment: 278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.